{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:39:21Z","timestamp":1780605561954,"version":"3.54.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Stevens-Johnson Syndrome (SJS) is a rare but potentially fatal skin reaction characterized by extensive involvement of the epidermal and mucosal tissue. Although medications are the typical culprits, infectious diseases and chronic illnesses may also trigger SJS or toxic epidermal necrolysis (TEN). We present a rapid, severe SJS\/TEN case in response to azithromycin administration, underscoring the critical need for pharmacovigilance and discontinuation of suspected medications, even if the potential causative agent is not commonly associated with these severe cutaneous adverse reactions.<\/jats:p>","DOI":"10.1093\/milmed\/usaf352","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:40:12Z","timestamp":1750750812000},"page":"e1314-e1318","source":"Crossref","is-referenced-by-count":1,"title":["An Uncommon Reaction to a Common Medication: Stevens-Johnson Syndrome Associated With Azithromycin"],"prefix":"10.1093","volume":"191","author":[{"given":"Jackson L","family":"Howell","sequence":"first","affiliation":[{"name":"81st Medical Group Keesler Air Force Base, Allergy and Immunology Clinic , Biloxi, Mississippi 39531,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra L","family":"Cochran","sequence":"additional","affiliation":[{"name":"81st Medical Group Keesler Air Force Base, Allergy and Immunology Clinic , Biloxi, Mississippi 39531,","place":["United States"]},{"name":"59th Medical Wing Lackland Air Force Base, Allergy and Immunology Clinic , San Antonio, Texas 78236,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittanie I","family":"Neaves","sequence":"additional","affiliation":[{"name":"81st Medical Group Keesler Air Force Base, Allergy and Immunology Clinic , Biloxi, Mississippi 39531,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Coop","sequence":"additional","affiliation":[{"name":"81st Medical Group Keesler Air Force Base, Allergy and Immunology Clinic , Biloxi, Mississippi 39531,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2026050517474062500_usaf352-B1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamadermatol.2016.0180","article-title":"Stevens-Johnson Syndrome: a look back","volume":"153","author":"Callahan","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2026050517474062500_usaf352-B2","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026050517474062500_usaf352-B3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijstd.IJSTD_61_19","article-title":"Study of genital manifestations of Stevens Johnson Syndrome\/toxic epidermal necrolysis","volume":"43","author":"Gulanikar","year":"2022","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"2026050517474062500_usaf352-B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2012.27.2.203","article-title":"Causes and treatment outcomes of Stevens-Johnson Syndrome and toxic epidermal necrolysis in 82 adult patients","volume":"27","author":"Kim","year":"2012","journal-title":"Korean J Intern Med"},{"key":"2026050517474062500_usaf352-B5","author":"Labib","year":"2025"},{"key":"2026050517474062500_usaf352-B6","doi-asserted-by":"crossref","first-page":"1117391","DOI":"10.3389\/fphar.2023.1117391","article-title":"Severe cutaneous adverse reactions to drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026050517474062500_usaf352-B7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/jfmpc.jfmpc_889_19","article-title":"Nikolsky\u2019s sign: a pathognomic boon","volume":"9","author":"Maity","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"2026050517474062500_usaf352-B8","first-page":"52","article-title":"Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"90","author":"Liotti","year":"2019","journal-title":"Acta Biomed"},{"key":"2026050517474062500_usaf352-B9","year":"2024"},{"key":"2026050517474062500_usaf352-B10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaad.2021.04.066","article-title":"Mycoplasma-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis: case-control analysis of a cohort managed in a specialized center","volume":"86","author":"Liew","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026050517474062500_usaf352-B11","first-page":"e49289","article-title":"A multifactorial case of Stevens-Johnson Syndrome with atypical features","volume":"15","author":"Paterno","year":"2023","journal-title":"Cureus"},{"key":"2026050517474062500_usaf352-B12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/1346-8138.15968","article-title":"Neutrophil: lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson Syndrome\/toxic epidermal necrolysis","volume":"48","author":"Wang","year":"2021","journal-title":"J Dermatol"},{"key":"2026050517474062500_usaf352-B13","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050517474062500_usaf352-B14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B1502 allele and carbamazepine-induced Stevens-Johnson Syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2026050517474062500_usaf352-B15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson Syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026050517474062500_usaf352-B16","author":"Oakley","year":"2025"},{"key":"2026050517474062500_usaf352-B17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ijd.15144","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases","volume":"60","author":"Pej\u010di\u0107","year":"2021","journal-title":"Int J Dermatol"},{"key":"2026050517474062500_usaf352-B18","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20419.1","article-title":"Pediatric SJS-TEN: where are we now?","volume":"9","author":"Ramien","year":"2020","journal-title":"F1000Res"},{"key":"2026050517474062500_usaf352-B19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens-Johnson Syndrome and toxic epidermal necrolysis: diagnosis and management","volume":"25","author":"Shah","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"2026050517474062500_usaf352-B20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2019.05.061","article-title":"Distinguishing Stevens-Johnson Syndrome\/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation: a retrospective chart review","volume":"81","author":"Weinkle","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026050517474062500_usaf352-B21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026050517474062500_usaf352-B22","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7574.1","article-title":"Toxic epidermal necrolysis","volume":"5","author":"Hoetzenecker","year":"2016","journal-title":"F1000Res"},{"key":"2026050517474062500_usaf352-B23","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaad.2020.02.066","article-title":"Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson Syndrome\/toxic epidermal necrolysis in adults","volume":"82","author":"Seminario-Vidal","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026050517474062500_usaf352-B24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson Syndrome\/toxic epidermal necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"2026050517474062500_usaf352-B25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2332\/allergolint.55.27","article-title":"Immune mechanisms in drug allergy","volume":"55","author":"Roujeau","year":"2006","journal-title":"Allergol Int"},{"key":"2026050517474062500_usaf352-B26","first-page":"329","article-title":"Severe cutaneous adverse reactions due to inappropriate medication use","volume":"179","author":"Chaby","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026050517474062500_usaf352-B27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/ph17060675","article-title":"Stevens-Johnson Syndrome and toxic epidermal necrolysis: analysis of the Russian database of spontaneous reports","volume":"17","author":"Zyryanov","year":"2024","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/5-6\/e1314\/63884020\/usaf352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/191\/5-6\/e1314\/63884020\/usaf352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:17:18Z","timestamp":1778019438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/191\/5-6\/e1314\/8217813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":27,"journal-issue":{"issue":"5-6","published-online":{"date-parts":[[2025,6,27]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf352","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,6,27]]}}}